13,263
Views
121
CrossRef citations to date
0
Altmetric
Review

How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3)

, , , , &
Pages 723-732 | Received 26 Apr 2016, Accepted 07 Oct 2016, Published online: 21 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Eliana C. Ferretti, Erica Suzumura, Luciana M. Rozman, Rory A. Cooper & Patrícia C. de Soárez. (2023) Economic evaluation of wheelchairs interventions: a systematic review. Disability and Rehabilitation: Assistive Technology 18:7, pages 1163-1174.
Read now
Sinaa Al-Aqeel, Joud Alsugair & Ruba Alghamdi. (2023) Economic evaluation of interventions to improve medication adherence among patients with chronic diseases: an overview of systematic reviews. Expert Review of Pharmacoeconomics & Outcomes Research 23:2, pages 153-179.
Read now
Rieka von der Warth, Judith Dams, Thomas Grochtdreis & Hans-Helmut König. (2020) Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review. European Journal of Psychotraumatology 11:1.
Read now
Kevin Bowrin, Jean-Baptiste Briere, Pierre Levy, Mondher Toumi & Aurélie Millier. (2020) Use of real-world evidence in meta-analyses and cost-effectiveness models. Journal of Medical Economics 23:10, pages 1053-1060.
Read now
T. A. Rautenberg, G. George, M. B. Bwana, M. S. Moosa, S. Pillay, S. M. McCluskey, I. Aturinda, K. Ard, W. Muyindike, P. Moodley, J. Brijkumar, B. A. Johnson, R. T. Gandhi, H. Sunpath, V. C. Marconi & M. J. Siedner. (2020) Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models. Journal of Medical Economics 23:3, pages 221-227.
Read now
Inês Souto Ribeiro, Francisco Jorge Batel Marques, Dalila Gil Alves & Carlos Miguel Costa Alves. (2019) A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs. Expert Review of Pharmacoeconomics & Outcomes Research 19:4, pages 421-430.
Read now
FW Thielen, GAPG Van Mastrigt, LT Burgers, WM Bramer, HJM Majoie, SMAA Evers & J Kleijnen. (2016) How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3). Expert Review of Pharmacoeconomics & Outcomes Research 16:6, pages 705-721.
Read now
Ghislaine A.P.G. van Mastrigt, Mickaël Hiligsmann, Jacobus J.C. Arts, Pieter H. Broos, Jos Kleijnen, Silvia M.A.A. Evers & Marian H.J.M. Majoie. (2016) How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3). Expert Review of Pharmacoeconomics & Outcomes Research 16:6, pages 689-704.
Read now

Articles from other publishers (113)

Ramesh Lamsal, E. Ann Yeh, Eleanor Pullenayegum & Wendy J. Ungar. (2023) A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effects. PharmacoEconomics.
Crossref
Hoi Yau Chan, Luca M. M. Janssen, Ben F. M. Wijnen, Mickaël Hiligsmann, Marian H. J. M. Majoie & Silvia M. A. A. Evers. (2023) Economic evaluations of nonpharmacological treatments for drug‐resistant epilepsy: A systematic review. Epilepsia 64:11, pages 2861-2877.
Crossref
Lieke C.J. van Delft, Nicole W.J. Kelleners-Smeets, Andrea Peeters, Klara Mosterd & Brigitte A.B. Essers. (2023) A systematic review of economic evaluations for the interventions of superficial basal cell carcinoma. EJC Skin Cancer, pages 100008.
Crossref
Ruben Willems, Lieven Annemans, George Siopis, George Moschonis, Rajesh Vedanthan, Jenny Jung, Dominika Kwasnicka, Brian Oldenburg, Claudia d’Antonio, Sandro Girolami, Eirini Agapidaki, Yannis Manios, Nick Verhaeghe, Natalya Usheva, Violeta Iotova, Andreas Triantafyllidis, Konstantinos Votis, Florian Toti, Konstantinos Makrilakis, Chiara Seghieri, Luis Moreno, Sabine Dupont, Leo Lewis, Djordje Djokic & Helen Skouteris. (2023) Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension. npj Digital Medicine 6:1.
Crossref
M. Rifqi Rokhman, Firas Farisi Alkaff, Pim W.M. van Dorst, Jarir At Thobari, Maarten J. Postma, Jurjen van der Schans & Cornelis Boersma. (2023) Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review. Value in Health.
Crossref
Tanja Rombey, Helene Eckhardt, Jörn Kiselev, Julia Silzle, Tim Mathes & Wilm Quentin. (2023) Cost-effectiveness of prehabilitation prior to elective surgery: a systematic review of economic evaluations. BMC Medicine 21:1.
Crossref
Katja C. Heinz, Charlotte Beaudart, Damon Willems, Isabell Wiethoff & Mickaël Hiligsmann. (2023) Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review. PharmacoEconomics.
Crossref
Tom Kugener, Isabell Wiethoff, Ghislaine van Mastrigt, Bram van den Berg & Silvia M. A. A. Evers. (2023) Economic evaluations of interventions focusing on child abuse and neglect in high-income countries: a systematic review. Frontiers in Psychiatry 14.
Crossref
Isobel M Dorling, Lars Geenen, Marion J L F Heymans, Jasper Most, Bert Boonen & Martijn G M Schotanus. (2023) Cost-effectiveness of patient specific vs conventional instrumentation for total knee arthroplasty: A systematic review and meta-analysis . World Journal of Orthopedics 14:6, pages 458-470.
Crossref
Samuel W.D. Merriel, Rebekah Hall, Fiona M. Walter, Willie Hamilton & Anne E. Spencer. (2023) Systematic Review and Narrative Synthesis of Economic Evaluations of Prostate Cancer Diagnostic Pathways Incorporating Prebiopsy Magnetic Resonance Imaging. European Urology Open Science 52, pages 123-134.
Crossref
Isabell Wiethoff, Birgit Goversen, Michelle Michels, Jolanda van der Velden, Mickaël Hiligsmann, Tom Kugener & Silvia M. A. A. Evers. (2023) A systematic literature review of economic evaluations and cost-of-illness studies of inherited cardiomyopathies. Netherlands Heart Journal.
Crossref
Giulia Osório Santana, Rodrigo de Macedo Couto, Rafael Maffei Loureiro, Brunna Carolinne Rocha Silva, Edna Terezinha Rother, Joselisa Péres Queiroz de Paiva & Lucas Reis Correia. (2023) Economic evaluations and equity in the use of artificial intelligence in imaging exams for medical diagnosis in people with skin, neurological and pulmonary diseases: a systematic review protocol (Preprint). JMIR Research Protocols.
Crossref
Thinni Nurul Rochmah, Aulia Ramadhani, Taufan Bramantoro, Lucindari Gea Permata & Tin Zar Tun. (2023) Systematic review on cost-effectiveness analysis of school-based oral health promotion program. PLOS ONE 18:4, pages e0284518.
Crossref
Katherine Pye, Hannah Jackson, Teresa Iacono & Alan Shiell. (2023) Economic Evaluation of Early Interventions for Autistic Children: A Scoping Review. Journal of Autism and Developmental Disorders.
Crossref
Ruud Droeghaag, Valérie N E Schuermans, Sem M M Hermans, Anouk Y J M Smeets, Inge J M H Caelers, Mickaël Hiligsmann, Silvia Evers, Wouter L W van Hemert & Henk van Santbrink. (2023) Methodology of economic evaluations in spine surgery: a systematic review and qualitative assessment. BMJ Open 13:3, pages e067871.
Crossref
Marina B Pinheiro, Kirsten Howard, Juliana S Oliveira, Wing S Kwok, Anne Tiedemann, Belinda Wang, Jennifer Taylor, Adrian Bauman & Catherine Sherrington. (2023) Cost-effectiveness of physical activity programs and services for older adults: a scoping review. Age and Ageing 52:3.
Crossref
Amrit Banstola, Subhash Pokhrel, Benedict Hayhoe, Dasha Nicholls, Matthew Harris & Nana Anokye. (2023) Economic evaluations of interventional opportunities for the management of mental–physical multimorbidity: a systematic review. BMJ Open 13:2, pages e069270.
Crossref
Patricia Coelho de Soarez, Luciana Martins Rozman, Taiane Siraisi Fonseca, Pietro Rodrigo Borsari, Jadher Percio, Lely Stella Guzmán Barrera & Ana Marli Christovam Sartori. (2023) The methodological quality of economic evaluations of measles outbreaks: A systematic review of cost-of-illness studies. Vaccine 41:7, pages 1319-1332.
Crossref
Fernando Henrique de Albuquerque Maia, Luciana Martins Rozman, Heloisa de Andrade Carvalho & Patrícia Coelho de Soárez. (2023) Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Medine Yılmaz, Gamze Agartioglu Kundakci & Melih Kaan Sozmen. (2023) A Systematic Review of Economic Evaluations of Fall Prevention Interventions for Community-Dwelling Older People. Journal of Aging and Long-Term Care, pages 35-55.
Crossref
Antonio Olry de Labry-Lima, Angela Ponce-Polo, Leticia García-Mochón, Marta Ortega-Ortega, Daniel Pérez-Troncoso & David Epstein. (2023) Challenges for Economic Evaluations of Advanced Therapy Medicinal Products: A Systematic Review. Value in Health 26:1, pages 138-150.
Crossref
Meryl Darlington, Raffaele Scarica, Xyomara Chavez-Pacheco, Laeticia Blamplain Segar & Isabelle Durand-Zaleski. (2022) Decrementally cost-effective health technologies in non-inferiority studies: A systematic review. Frontiers in Pharmacology 13.
Crossref
Nguyen Thu Ha, Nguyen Thanh Huong, Vu Nguyen Anh & Nguyen Quynh Anh. (2022) Modelling in economic evaluation of mental health prevention: current status and quality of studies. BMC Health Services Research 22:1.
Crossref
Alina Weise, Roland Brian Büchter, Dawid Pieper & Tim Mathes. (2022) Assessing transferability in systematic reviews of health economic evaluations – a review of methodological guidance. BMC Medical Research Methodology 22:1.
Crossref
Lena Schnitzler, Silvia M. A. A. Evers, Louise J. Jackson, Aggie T. G. Paulus & Tracy E. Roberts. (2022) Are intersectoral costs considered in economic evaluations of interventions relating to sexually transmitted infections (STIs)? A systematic review. BMC Public Health 22:1.
Crossref
Melissa Murano, Doris Chou, Maria Laura Costa & Tari Turner. (2022) Using the WHO-INTEGRATE evidence-to-decision framework to develop recommendations for induction of labour. Health Research Policy and Systems 20:1.
Crossref
Marina B Pinheiro, Catherine Sherrington, Kirsten Howard, Patrick Caldwell, Anne Tiedemann, Belinda Wang, Juliana S Oliveira, Andreia Santos, Fiona C Bull, Juana F Willumsen, Zoe A Michaleff, Sarah Ferguson, Eleesheva Mayo, Nicola J Fairhall, Adrian E Bauman & Sarah Norris. (2022) Economic evaluations of fall prevention exercise programs: a systematic review. British Journal of Sports Medicine, pages bjsports-2022-105747.
Crossref
Lynne Moore, Jason Robert Guertin, Pier-Alexandre Tardif, Noah Michael Ivers, Jeffrey Hoch, Blanchard Conombo, Jesmin Antony, Henry Thomas Stelfox, Simon Berthelot, Patrick Archambault, Alexis Turgeon, Rohit Gandhi & JM Grimshaw. (2022) Economic evaluations of audit and feedback interventions: a systematic review. BMJ Quality & Safety 31:10, pages 754-767.
Crossref
Marina B. Pinheiro, Kirsten Howard, Cathie Sherrington, Adrian Bauman, Nathalia Costa, Ben J. Smith, William Bellew, Ding Ding, Anne Tiedemann, Belinda Wang, Andreia C Santos, Fiona Bull, Juana Willumsen, Bruna S. Albuquerque, Frances Rom Lunar, Vishwesh Bapat & Sarah K. Norris. (2022) Economic evaluation of physical activity mass media campaigns across the globe: a systematic review. International Journal of Behavioral Nutrition and Physical Activity 19:1.
Crossref
Thatohatsi Sefuthi & Lungiswa Nkonki. (2022) A systematic review of economic evaluations of cervical cancer screening methods. Systematic Reviews 11:1.
Crossref
John J. Riva, Meha Bhatt, Carolina C. Martins, David J. Brunarski, Jason W. Busse, Feng Xie, Holger J. Schünemann & Jan L. Brozek. (2022) Indirectness (transferability) is critical when considering existing economic evaluations for GRADE clinical practice guidelines: a systematic review. Journal of Clinical Epidemiology 148, pages 81-92.
Crossref
Ajeng V Icanervilia, Jurjen van der Schans, Qi Cao, Adriana C de Carvalho, Kathya Cordova-Pozo, Jarir At Thobari, Maarten J Postma & Antoinette DI van Asselt. (2022) Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: A systematic review. Journal of Global Health 12.
Crossref
Elizabeth Sebastian, Chloe Bykersma, Alexander Eggleston, Katherine E. Eddy, Sher Ting Chim, Rana Islamiah Zahroh, Nick Scott, Doris Chou, Olufemi T. Oladapo & Joshua P. Vogel. (2022) Cost-effectiveness of antenatal corticosteroids and tocolytic agents in the management of preterm birth: A systematic review. eClinicalMedicine 49, pages 101496.
Crossref
Katelyn A Barnes, Zoe Szewczyk, Jaimon T Kelly, Katrina L Campbell & Lauren E Ball. (2022) How cost-effective is nutrition care delivered in primary healthcare settings? A systematic review of trial-based economic evaluations. Nutrition Reviews 80:6, pages 1480-1496.
Crossref
Ivan Yanev, Jessy GateteJr.Jr., Armen G. Aprikian, Jason Robert Guertin & Alice Dragomir. (2022) The Health Economics of Metastatic Hormone-Sensitive and Non-Metastatic Castration-Resistant Prostate Cancer—A Systematic Literature Review with Application to the Canadian Context. Current Oncology 29:5, pages 3393-3424.
Crossref
Asif Sukri, Mohd Zaki Salleh, Collen Masimirembwa & Lay Kek Teh. (2022) A systematic review on the cost effectiveness of pharmacogenomics in developing countries: implementation challenges. The Pharmacogenomics Journal 22:3, pages 147-159.
Crossref
V. N. E. Schuermans, A. Y. J. M. Smeets, A. F. M. Boselie, O. Zarrouk, S. M. M. Hermans, R. Droeghaag, I. Curfs, S. M. A. A. Evers & H. van Santbrink. (2022) Cost-effectiveness of anterior surgical decompression surgery for cervical degenerative disk disease: a systematic review of economic evaluations. European Spine Journal 31:5, pages 1206-1218.
Crossref
Daniel Erku, Amanual G Mersha, Eskinder Eshetu Ali, Gebremedhin B Gebretekle, Befikadu L Wubishet, Gizat Molla Kassie, Anwar Mulugeta, Alemayehu B Mekonnen, Tesfahun C Eshetie & Paul Scuffham. (2022) A systematic review of scope and quality of health economic evaluations conducted in Ethiopia. Health Policy and Planning 37:4, pages 514-522.
Crossref
Wilson Bautista-Molano, Lina M. Saldarriaga-Rivera, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jauregui, Juan S. Segura-Charry, Consuelo Romero-Sanchez & Oscar J. Felipe-Diaz. (2022) 2021 clinical practice guideline for the early detection, diagnosis, treatment, and monitoring of patients with axial spondyloarthritis. Colombian Association of Rheumatology. Reumatología Clínica (English Edition) 18:4, pages 191-199.
Crossref
Wilson Bautista-Molano, Lina M. Saldarriaga-Rivera, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jauregui, Juan S. Segura-Charry, Consuelo Romero-Sanchez & Oscar J. Felipe-Diaz. (2022) Guía de práctica clínica 2021 para la detección temprana, el diagnóstico, el tratamiento y el seguimiento de los pacientes con espondiloartritis axial. Asociación Colombiana de Reumatología. Reumatología Clínica 18:4, pages 191-199.
Crossref
Wilson Bautista-Molano, Lina M. Saldarriaga-Rivera, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jauregui, Juan S. Segura-Charry, Consuelo Romero-Sanchez & Oscar J. Felipe-Diaz. (2022) 2021 clinical practice guideline for the early detection, diagnosis, treatment, and monitoring of patients with axial spondyloarthritis. Colombian Association of Rheumatology. Revista Colombiana de Reumatología (English Edition) 29:2, pages 113-124.
Crossref
Wilson Bautista-Molano, Lina M. Saldarriaga-Rivera, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jauregui, Juan S. Segura-Charry, Consuelo Romero-Sanchez & Oscar J. Felipe-Diaz. (2022) Guía de práctica clínica 2021 para la detección temprana, el diagnóstico, el tratamiento y el seguimiento de los pacientes con espondiloartritis axial. Asociación Colombiana de Reumatología. Revista Colombiana de Reumatología 29:2, pages 113-124.
Crossref
Ahmad Amir Kamil, Ka Keat Lim, Rositsa Koleva-Kolarova, Philip Chowienczyk, Charles D.A. Wolfe & Julia Fox-Rushby. (2022) Genetic-Guided Pharmacotherapy for Atrial Fibrillation: A Systematic and Critical Review of Economic Evaluations. Value in Health 25:3, pages 461-472.
Crossref
Sónia Romano, Débora Figueira, Inês Teixeira & Julian Perelman. (2021) Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations. PharmacoEconomics 40:3, pages 269-295.
Crossref
Amber Werbrouck, Masja Schmidt, Koen Putman, Jan Seghers, Steven Simoens, Nick Verhaeghe & Lieven Annemans. (2022) Cost-effectiveness of exercise referral schemes: a systematic review of health economic studies. European Journal of Public Health 32:1, pages 87-94.
Crossref
Lieke Fleur Heupink, Elizabeth Fleur Peacocke, Ingvil Sæterdal, Lumbwe Chola & Katrine Frønsdal. (2022) Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices. International Journal of Technology Assessment in Health Care 38:1.
Crossref
Lina M. Saldarriaga-Rivera, Wilson Bautista-Molano, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jáuregui, Juan S. Segura-Charry, Consuelo Romero-Sánchez & Oscar J. Felipe-Diaz. (2022) 2021 clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with peripheral spondyloarthritis. Colombian Association of Rheumatology. Reumatología Clínica (English Edition) 18:1, pages 5-14.
Crossref
Lina M. Saldarriaga-Rivera, Wilson Bautista-Molano, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jáuregui, Juan S. Segura-Charry, Consuelo Romero-Sánchez & Oscar J. Felipe-Diaz. (2022) Guía de práctica clínica 2021 para el diagnóstico, el tratamiento y el seguimiento de pacientes con espondiloartritis periférica. Asociación Colombiana de Reumatología. Reumatología Clínica 18:1, pages 5-14.
Crossref
Lina M. Saldarriaga-Rivera, Wilson Bautista-Molano, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jáuregui, Juan S. Segura-Charry, Consuelo Romero-Sánchez & Oscar J. Felipe-Diaz. (2022) 2021 clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with peripheral spondyloarthritis. Colombian Association of Rheumatology. Revista Colombiana de Reumatología (English Edition) 29:1, pages 44-56.
Crossref
Lina M. Saldarriaga-Rivera, Wilson Bautista-Molano, Alejandro Junca-Ramírez, Andrés R. Fernández-Aldana, Daniel G. Fernández-Ávila, Diego A. Jaimes, Edwin A. Jáuregui, Juan S. Segura-Charry, Consuelo Romero-Sánchez & Oscar J. Felipe-Diaz. (2022) Guía de práctica clínica 2021 para el diagnóstico, el tratamiento y el seguimiento de pacientes con espondiloartritis periférica. Asociación Colombiana de Reumatología. Revista Colombiana de Reumatología 29:1, pages 44-56.
Crossref
Edna Keeney, Howard Thom, Emma Turner, Richard M. Martin, Josie Morley & Sabina Sanghera. (2022) Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis. Value in Health 25:1, pages 133-146.
Crossref
Arman S. Walia, Randy F. Sweis, Piyush K. Agarwal, Andrew K. Kader & Parth K. Modi. (2021) Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma—A Review. Cancers 14:1, pages 73.
Crossref
Katherine Pye, Hannah Jackson, Teresa Iacono & Alan Shiell. (2021) Early intervention for young children with autism spectrum disorder: protocol for a scoping review of economic evaluations. Systematic Reviews 10:1.
Crossref
Alemayehu Hailu, Getachew Teshome Eregata, Amanuel Yigezu, Melanie Y. Bertram, Kjell Arne Johansson & Ole F. Norheim. (2021) Contextualization of cost-effectiveness evidence from literature for 382 health interventions for the Ethiopian essential health services package revision. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Lena Schnitzler, Louise J. Jackson, Aggie T. G. Paulus, Tracy E. Roberts & Silvia M. A. A. Evers. (2021) Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness (COI) studies. BMC Health Services Research 21:1.
Crossref
J.K. Peel, S. Keshavjee, M. Krahn & B. Sander. (2021) Economic evaluations and costing studies of lung transplantation: A scoping review. The Journal of Heart and Lung Transplantation 40:12, pages 1625-1640.
Crossref
Cate Bailey, Helen Skouteris, Heather Morris, Renee O’Donnell, Briony Hill & Zanfina Ademi. (2021) Economic evaluation methods used in home‐visiting interventions: A systematic search and review. Health & Social Care in the Community 29:6, pages 1650-1667.
Crossref
Daniel Erku, Shakti Shrestha & Paul Scuffham. (2021) Cost-Effectiveness of Medicinal Cannabis for Management of Refractory Symptoms Associated With Chronic Conditions: A Systematic Review of Economic Evaluations. Value in Health 24:10, pages 1520-1530.
Crossref
Glenn Leemans, Jan Taeymans, Paul Van Royen & Dirk Vissers. (2021) Respiratory physiotherapy interventions focused on exercise training and enhancing physical activity levels in people with chronic obstructive pulmonary disease are likely to be cost-effective: a systematic review. Journal of Physiotherapy 67:4, pages 271-283.
Crossref
Alessandra Løchen & Roy M. Anderson. (2021) Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations. Clinical Microbiology and Infection 27:10, pages 1546-1557.
Crossref
Laurent Frossard. (2021) TRENDS AND OPPORTUNITIES IN HEALTH ECONOMIC EVALUATIONS OF PROSTHETIC CARE INNOVATIONS. CANADIAN PROSTHETICS & ORTHOTICS JOURNAL 4:2.
Crossref
Francesca Brundisini, Hervé Tchala Vignon Zomahoun, France Légaré, Nathalie Rhéault, Claude Bernard-Uwizeye, José Massougbodji, Amédé Gogovor, Sébastien Tchoubi, Odilon Assan & Maude Laberge. (2021) Economic evaluations of scaling up strategies of evidence-based health interventions: a systematic review protocol. BMJ Open 11:9, pages e050838.
Crossref
Shah Alam Khan, Karla Vanessa Hernandez‐Villafuerte, Muchandifunga Trust Muchadeyi & Michael Schlander. (2021) Cost‐effectiveness of risk‐based breast cancer screening: A systematic review. International Journal of Cancer 149:4, pages 790-810.
Crossref
Sonia Conejo-Cerón, Joran Lokkerbol, Patricia Moreno-Peral, Ben Wijnen, Anna Fernández, Juan M. Mendive, Filip Smit & Juan Ángel Bellón. (2021) Health-economic evaluation of psychological interventions for depression prevention: Systematic review. Clinical Psychology Review 88, pages 102064.
Crossref
Drishti Baid, Edward Hayles & Eric A. Finkelstein. (2021) Return on Investment of Workplace Wellness Programs for Chronic Disease Prevention: A Systematic Review. American Journal of Preventive Medicine 61:2, pages 256-266.
Crossref
Irina Pokhilenko, Luca M. M. Janssen, Silvia M. A. A. Evers, Ruben M. W. A. Drost, Lena Schnitzler & Aggie T. G. Paulus. (2021) Do Costs in the Education Sector Matter? A Systematic Literature Review of the Economic Impact of Psychosocial Problems on the Education Sector. PharmacoEconomics 39:8, pages 889-900.
Crossref
Kristina Kast, Carl-Philipp Wachter, Oliver Schöffski & Martina Rimmele. (2021) Economic evidence with respect to cost-effectiveness of the transitional care model among geriatric patients discharged from hospital to home: a systematic review. The European Journal of Health Economics 22:6, pages 961-975.
Crossref
Mayara Fontes Marx, John E. Ataguba, Jantina de Vries & Ambroise Wonkam. (2021) Systematic Review of the Economic Evaluation of Returning Incidental Findings in Genomic Research. Frontiers in Public Health 9.
Crossref
Danmeng Huang, Steven J. Frank, Vivek Verma, Nikhil G. Thaker, Eric D. Brooks, Matthew B. Palmer, Ross F. Harrison, Ashish A. Deshmukh & Matthew S. Ning. (2021) Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date. International Journal of Particle Therapy 8:1, pages 339-353.
Crossref
Ruud Droeghaag, Sem M.M. Hermans, Inge J.M.H. Caelers, Silvia M.A.A. Evers, Wouter L.W. van Hemert & Henk van Santbrink. (2021) Cost-effectiveness of open transforaminal lumbar interbody fusion (OTLIF) versus minimally invasive transforaminal lumbar interbody fusion (MITLIF): a systematic review and meta-analysis. The Spine Journal 21:6, pages 945-954.
Crossref
Francesco Ramponi, Wiktoria Tafesse & Susan Griffin. (2021) Economic evaluation of interventions to address undernutrition: a systematic review. Health Policy and Planning 36:4, pages 533-541.
Crossref
Alfredo Palacios, Carlos Rojas-Roque, Lucas González, Ariel Bardach, Agustín Ciapponi, Claudia Peckaitis, Andres Pichon-Riviere & Federico Augustovski. (2021) Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review. PharmacoEconomics 39:5, pages 485-502.
Crossref
Olena (Lena) Mandrik, J.L. (Hans) Severens, Ariel Bardach, Salah Ghabri, Candyce Hamel, Tim Mathes, Luke Vale, Torbjørn Wisløff & Jeremy D. Goldhaber-Fiebert. (2021) Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report. Value in Health 24:4, pages 463-472.
Crossref
D.R. Mazzei, A. Ademola, J.H. Abbott, T. Sajobi, K. Hildebrand & D.A. Marshall. (2021) Are education, exercise and diet interventions a cost-effective treatment to manage hip and knee osteoarthritis? A systematic review. Osteoarthritis and Cartilage 29:4, pages 456-470.
Crossref
Milanne M.J. Galekop, Carin A. Uyl-de Groot & W. Ken Redekop. (2021) A Systematic Review of Cost-Effectiveness Studies of Interventions With a Personalized Nutrition Component in Adults. Value in Health 24:3, pages 325-335.
Crossref
Inge J. M. H. Caelers, Suzanne L. de Kunder, Kim Rijkers, Wouter L. W. van Hemert, Rob A. de Bie, Silvia M. A. A. Evers & Henk van Santbrink. (2021) Comparison of (Partial) economic evaluations of transforaminal lumbar interbody fusion (TLIF) versus Posterior lumbar interbody fusion (PLIF) in adults with lumbar spondylolisthesis: A systematic review. PLOS ONE 16:2, pages e0245963.
Crossref
Zoe Szewczyk, Elizabeth Holliday, Brittany Dean, Clare Collins & Penny Reeves. (2021) A systematic review of economic evaluations of antenatal nutrition and alcohol interventions and their associated implementation interventions. Nutrition Reviews 79:3, pages 261-273.
Crossref
Darren R. Mazzei, Ayoola Ademola, J. Haxby Abbott, Tolulpe Sajobi, Kevin Hildebrand & Deborah A. Marshall. (2020) Systematic review of economic evaluations investigating education, exercise, and dietary weight management to manage hip and knee osteoarthritis: protocol. Systematic Reviews 9:1.
Crossref
Tanja Rombey, Helene Eckhardt & Wilm Quentin. (2020) Cost-effectiveness of prehabilitation prior to elective surgery compared to usual preoperative care: protocol for a systematic review of economic evaluations. BMJ Open 10:12, pages e040262.
Crossref
Angelica Carletto, Matteo Zanuzzi, Annalisa Sammarco & Pierluigi Russo. (2020) Quality of health economic evaluations submitted to the Italian Medicines Agency: current state and future actions. International Journal of Technology Assessment in Health Care 36:6, pages 560-568.
Crossref
Jannis T. Kraiss, Ben Wijnen, Ralph W. Kupka, Ernst T. Bohlmeijer & Joran Lokkerbol. (2020) Economic evaluations of non-pharmacological interventions and cost-of-illness studies in bipolar disorder: A systematic review. Journal of Affective Disorders 276, pages 388-401.
Crossref
Bernard O. Okeah & Colin H. Ridyard. (2020) Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review. Applied Health Economics and Health Policy 18:5, pages 641-654.
Crossref
Pau Redón, Atif Shahzad, Talha Iqbal & William Wijns. (2020) Benefits of Home-Based Solutions for Diagnosis and Treatment of Acute Coronary Syndromes on Health Care Costs: A Systematic Review. Sensors 20:17, pages 5006.
Crossref
Aziz Rezapour, Hossein Bouzarjomehri, Akhtar Shah-Savandi, Emad Karimianrad, Narges Pirani, Jalal Arabloo, Samira Soleimanpoor & Yasaman Herandi. (2020) Cost-effectiveness of digital mammography compared to film mammography in screening of breast cancer: a systematic review. Annals of Cancer Research and Therapy 28:2, pages 118-124.
Crossref
João Pedro Steinhauser Motta, Ricardo E. Steffen, Caroliny Samary Lobato, Vanessa Souza Mendonça & José Roberto Lapa e Silva. (2020) Endobronchial ultrasound-guided transbronchial needle aspiration versus mediastinoscopy for mediastinal staging of lung cancer: A systematic review of economic evaluation studies. PLOS ONE 15:6, pages e0235479.
Crossref
Ashley Layer, Emma McManus & N. J. Levell. (2019) A Systematic Review of Model-Based Economic Evaluations of Treatments for Venous Leg Ulcers. PharmacoEconomics - Open 4:2, pages 211-222.
Crossref
Claudia Fischer, Eva Chwala & Judit Simon. (2020) Methodological aspects of economic evaluations conducted in the palliative or end of life care settings: a systematic review protocol. BMJ Open 10:5, pages e035760.
Crossref
Inês Ribeiro, Francisco Batel Marques, Dalila Alves & Carlos Alves. (2020) An analysis of the effectiveness outcomes of economic studies evaluating ophthalmic drugs: a systematic review. Acta Ophthalmologica 98:3, pages 237-243.
Crossref
Renato Mattli, Renato Farcher, Maria-Eleni Syleouni, Simon Wieser, Nicole Probst-Hensch, Arno Schmidt-Trucksäss & Matthias Schwenkglenks. (2019) Physical Activity Interventions for Primary Prevention in Adults: A Systematic Review of Randomized Controlled Trial-Based Economic Evaluations. Sports Medicine 50:4, pages 731-750.
Crossref
Masja Schmidt, Amber Werbrouck, Nick Verhaeghe, Koen Putman, Steven Simoens & Lieven Annemans. (2019) Universal Mental Health Interventions for Children and Adolescents: A Systematic Review of Health Economic Evaluations. Applied Health Economics and Health Policy 18:2, pages 155-175.
Crossref
Catherine Hanna, Theresa A Lawrie, Ewelina Rogozińska, Ashleigh Kernohan, Sarah Jefferies, Helen Bulbeck, Usama M Ali, Tomos Robinson & Robin Grant. (2020) Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Elisabet Jacobsen, Dwayne Boyers & Alison Avenell. (2020) Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study. PharmacoEconomics 38:3, pages 259-267.
Crossref
Tessa De Vrieze, Ines Nevelsteen, Sarah Thomis, An De Groef, Wiebren A. A. Tjalma, Nick Gebruers & Nele Devoogdt. (2019) What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review. Supportive Care in Cancer 28:2, pages 439-449.
Crossref
A. Løchen & R.M. Anderson. (2020) Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations. Clinical Microbiology and Infection 26:1, pages 60-70.
Crossref
Gerard Thompson, Theresa A Lawrie, Ashleigh Kernohan & Michael D Jenkinson. (2019) Interval brain imaging for adults with cerebral glioma. Cochrane Database of Systematic Reviews.
Crossref
Peter Lee, Ken Chin, Danny Liew, Dion Stub, Angela L Brennan, Jeffrey Lefkovits & Ella Zomer. (2019) Economic evaluation of clinical quality registries: a systematic review. BMJ Open 9:12, pages e030984.
Crossref
Andrea Juliana Sanabria, Anna Kotzeva, Anna Selva Olid, Sandra Pequeño, Robin W.M. Vernooij, Laura Martínez García, Yuan Zhang, Ivan Solà, Judith Thornton & Pablo Alonso-Coello. (2019) Most guideline organizations lack explicit guidance in how to incorporate cost considerations. Journal of Clinical Epidemiology 116, pages 72-83.
Crossref
Geert W. J. Frederix. (2019) Check Your Checklist: The Danger of Over- and Underestimating the Quality of Economic Evaluations. PharmacoEconomics - Open 3:4, pages 433-435.
Crossref
Carolina Castañeda Guerrero, Fernando De la Hoz Restrepo & Nelson Alvis Guzmán. (2019) Calidad en revisiones sistemáticas de evaluaciones económicas de tecnologías en salud.. Panorama Económico 27:3, pages 581-597.
Crossref
Nathanael Lutz, Jan Taeymans, Claudia Ballmer, Nick Verhaeghe, Peter Clarys & Tom Deliens. (2019) Cost-effectiveness and cost-benefit of worksite health promotion programs in Europe: a systematic review. European Journal of Public Health 29:3, pages 540-546.
Crossref
Tho Thi Hai Dang, David Rowell & Luke B. Connelly. (2019) Cost‐Effectiveness of Deep Brain Stimulation With Movement Disorders: A Systematic Review. Movement Disorders Clinical Practice 6:5, pages 348-358.
Crossref
Miriam Luhnen, Barbara Prediger, Edmund A.M. Neugebauer & Tim Mathes. (2019) Systematic reviews of health economic evaluations: A structured analysis of characteristics and methods applied. Research Synthesis Methods 10:2, pages 195-206.
Crossref
Noor Razilah Abdul Rafar, Yet Hoi Hong, David Bin-Chia Wu, Muhamad Faiz Othman & Chin Fen Neoh. (2019) Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review. Value in Health Regional Issues 18, pages 151-158.
Crossref
Theresa A Lawrie, Catherine R Hanna, Ewelina Rogozińska, Ashleigh Kernohan, Luke Vale, Helen Bulbeck, Usama M Ali & Robin Grant. (2019) Treatment of newly diagnosed glioblastoma in the elderly. Cochrane Database of Systematic Reviews.
Crossref
Mohsen Pakdaman, Rahele Akbari, Hamid Reza Dehghan, Reza Valagohar, Parastoo Rostami & Mahdieh Namayandeh. (2019) The Cost-effectiveness of Analogue Insulin Pens in Comparison with Human Insulin Pens for Controlling Type 1, Type 2, and Gestational Diabetes: A Systematic Review Article. Health Technology Assessment in Action In Press:In Press.
Crossref
Eva A Rehfuess, Jan M Stratil, Inger B Scheel, Anayda Portela, Susan L Norris & Rob Baltussen. (2019) The WHO-INTEGRATE evidence to decision framework version 1.0: integrating WHO norms and values and a complexity perspective. BMJ Global Health 4:Suppl 1, pages e000844.
Crossref
Amber Werbrouck, Masja Schmidt, Koen Putman, Katrien Benhalima, Nick Verhaeghe, Lieven Annemans & Steven Simoens. (2019) A systematic review on costs and cost-effectiveness of screening and prevention of type 2 diabetes in women with prior gestational diabetes: Exploring uncharted territory. Diabetes Research and Clinical Practice 147, pages 138-148.
Crossref
Anthony Pease, Clement Lo, Arul Earnest, Danny Liew & Sophia Zoungas. (2018) Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review. Systematic Reviews 7:1.
Crossref
Theresa A Lawrie, Ashleigh Kernohan, Michael D Jenkinson & Gerard Thompson. (2018) Interval brain imaging for adults with cerebral glioma. Cochrane Database of Systematic Reviews.
Crossref
Jacqueline Murphy, Mark G Pritchard, Lok Yin Cheng, Roshni Janarthanan & José Leal. (2018) Cost-effectiveness of enhanced recovery in hip and knee replacement: a systematic review protocol. BMJ Open 8:3, pages e019740.
Crossref
Andrés LasernaJulián Barahona-CorreaLaura BaqueroCamilo Castañeda-CardonaDiego Rosselli. (2018) Economic impact of dengue fever in Latin America and the Caribbean: a systematic review. Revista Panamericana de Salud Pública 42.
Crossref
Miriam Luhnen, Barbara Prediger, Edmund A.M. Neugebauer & Tim Mathes. (2018) SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS. International Journal of Technology Assessment in Health Care 34:6, pages 537-546.
Crossref
Miriam Luhnen, Barbara Prediger, Edmund A. M. Neugebauer & Tim Mathes. (2017) Systematic reviews of health economic evaluations: a protocol for a systematic review of characteristics and methods applied. Systematic Reviews 6:1.
Crossref